Loading clinical trials...
Loading clinical trials...
The goal of this study is to determine if topical SB-275833 ointment, 1% is more effective than a placebo ointment in the treatment of primary impetigo.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
GlaxoSmithKline
NCT02090764 · Impetigo
NCT01397461 · Impetigo
NCT01126268 · Impetigo, Folliculitis, and more
NCT01670032 · Impetigo
NCT01803035 · Non-bullous Impetigo
GSK Investigational Site
Bangalore
GSK Investigational Site
Hyderabad
GSK Investigational Site
Rome, Lazio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions